Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 2Recruiting 1

Sponsor Class

OTHER 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Breast Neoplasms 881Neoplasms 668Prostatic Neoplasms 455Lung Neoplasms 368Colorectal Neoplasms 335Carcinoma, Non-Small-Cell Lung 320Leukemia, Myeloid, Acute 257Pancreatic Neoplasms 224Brain Neoplasms 210Multiple Myeloma 204Neoplasm Metastasis 201Carcinoma, Hepatocellular 184Head and Neck Neoplasms 183Glioblastoma 170Precursor Cell Lymphoblastic Leukemia-Lymphoma 169Melanoma 159Ovarian Neoplasms 158Squamous Cell Carcinoma of Head and Neck 152Recurrence 139Rectal Neoplasms 137Hematologic Neoplasms 130Sarcoma 126Uterine Cervical Neoplasms 124Stomach Neoplasms 118Carcinoma, Renal Cell 118Triple Negative Breast Neoplasms 116Glioma 116Motor Activity 105Urinary Bladder Neoplasms 100Myelodysplastic Syndromes 99

Interventions

irinotecan sucrosofate 1camrelizumab 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Rectal Cancer Patients × 90 days × Clear all
NCT07389863 2026-05-05

GYNERECT

University Hospital, Rouen

Recruiting
15 enrolled
Gastrointestinal

Rectal Cancer Patients

NCT07557316 2026-04-29

Nodal Downstaging Versus Primary Tumor Regression as Predictors of Survival After Total Neoadjuvant Therapy for Rectal Cancer: A Retrospective Study

Sohag University

Not yet recruiting
100 enrolled
Gastrointestinal

Rectal Cancer Patients

NCT07521605 2026-04-13

Short-Course Radiotherapy, Nal-IRI, Capecitabine, and Camrelizumab for Locally Advanced MSS Rectal Cancer

Guangdong Provincial People's Hospital

Phase 2 Not yet recruiting
44 enrolled
Gastrointestinal

Rectal Cancer Patients

Data powered by HemOnc (CC BY 4.0) Colophon âš¡